Govt to provide Rs 900 crore for Covid Vaccine Research and Development
PBT Raises Rs 18 Crore on Social Stock Exchange for Free Healthcare Initiative
Advertisement
New Delhi: The government will provide Rs 900 crore to the Department of Biotechnology for the Covid Suraksha Mission, Finance Minister Nirmala Sitharaman said on Thursday while announcing another stimulus package, as part of 'Aatmanirbhar Bharat 3.0'.
The government grant will be used for research and development (R&D) of the Indian Covid vaccine.
Announcing the R&D fund, Sitharaman said that it would only cater to identified activity and would not cover the cost of vaccine or logistics required for its development. These will be provided separately, she said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.